DNLI - Denali Therapeutics EPS misses by $0.21 misses on revenue May, 03 2021 08:53 AM Denali Therapeutics Inc. Denali Therapeutics (DNLI): Q1 GAAP EPS of -$0.58 misses by $0.21.Revenue of $7.9M (+119.4% Y/Y) misses by $23.72M.Shares +2.58% PM.Press Release For further details see: Denali Therapeutics EPS misses by $0.21, misses on revenue